4880 — CellSource Co Balance Sheet
0.000.00%
- ¥13bn
- ¥9bn
- ¥4bn
Annual balance sheet for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,757 | 2,409 | 3,124 | 4,781 | 4,321 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 225 | 307 | 650 | 361 | 324 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,166 | 2,946 | 4,077 | 5,589 | 5,069 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 82.9 | 110 | 166 | 659 | 1,135 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,352 | 3,365 | 4,600 | 6,880 | 7,075 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 309 | 634 | 814 | 452 | 442 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 310 | 645 | 814 | 678 | 1,038 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,043 | 2,720 | 3,786 | 6,202 | 6,037 |
Total Liabilities & Shareholders' Equity | 2,352 | 3,365 | 4,600 | 6,880 | 7,075 |
Total Common Shares Outstanding |